Last reviewed · How we verify
Skin Prick Test - Atopic Subjects
At a glance
| Generic name | Skin Prick Test - Atopic Subjects |
|---|---|
| Sponsor | Roxall Medicina España S.A |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia (NA)
- Raman Analysis of Saliva as Biomarker of COPD
- The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy (NA)
- Skin Characteristics of Parents of Food Allergic Pediatric Patients
- Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects (NA)
- Identification of Epidermal Signatures in Patients With Atopic Dermatitis
- Determination of Biological Activity of Three Allergen Extracts (PHASE2)
- Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Skin Prick Test - Atopic Subjects CI brief — competitive landscape report
- Skin Prick Test - Atopic Subjects updates RSS · CI watch RSS
- Roxall Medicina España S.A portfolio CI